The DOI matches its Crossref record; 62 of the 62 references it cites were found in a registry or an index.
Anaphylatoxin C5a Creates a Favorable Microenvironment for Lung Cancer Progression
Open accessAbstract
The complement system contributes to various immune and inflammatory diseases, including cancer. In this study, we investigated the capacity of lung cancer cells to activate complement and characterized the consequences of complement activation on tumor progression. We focused our study on the production and role of the anaphylatoxin C5a, a potent immune mediator generated after complement activation. We first measured the capacity of lung cancer cell lines to deposit C5 and release C5a. C5 deposition, after incubation with normal human serum, was higher in lung cancer cell lines than in nonmalignant bronchial epithelial cells. Notably, lung malignant cells produced complement C5a even in the absence of serum. We also found a significant increase of C5a in plasma from patients with non-small cell lung cancer, suggesting that the local production of C5a is followed by its systemic diffusion. The contribution of C5a to lung cancer growth in vivo was evaluated in the Lewis lung cancer model. Syngeneic tumors of 3LL cells grew slower in mice treated with an antagonist of the C5a receptor. C5a did not modify 3LL cell proliferation in vitro but induced endothelial cell chemotaxis and blood-vessels formation. C5a also contributed to the immunosuppressive microenvironment required for tumor growth. In particular, blockade of C5a receptor significantly reduced myeloid-derived suppressor cells and immunomodulators ARG1, CTLA-4, IL-6, IL-10, LAG3, and PDL1 (B7H1). In conclusion, lung cancer cells have the capacity to generate C5a, a molecule that creates a favorable tumor microenvironment for lung cancer progression.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Safety, activity, and immune correlates of anti–PD-1 antibody in cancer
Topalian, S. L., Hodi, F. S., Brahmer, J. R., Gettinger, S. N., Smith, D. C., McDermott, D. F., Powderly, J. D., Carvajal, R. D., Sosman, J. A., Atkins, M. B., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1200690 · Cited by 12,628
Safety and activity of anti-PD-L1 antibody in patients with advanced cancer
Brahmer, J. R., Tykodi, S. S., Chow, L. Q. M., Hwu, W.-J., Topalian, S. L., Hwu, P., Drake, C. G., Camacho, L. H., Kauh, J., Odunsi, K., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1200694 · Cited by 7,945
Myeloid-derived-suppressor cells as regulators of the immune system
Gabrilovich, D. I., & Nagaraj, S. (2009) · Nature Reviews Immunology · doi:10.1038/nri2506 · Cited by 6,753
Tumor-associated B7-H1 promotes T-cell apoptosis: A potential mechanism of immune evasion
Dong, H., Strome, S. E., Salomao, D. R., Tamura, H., Hirano, F., Flies, D. B., Roche, P. C., Lu, J., Zhu, G., Tamada, K., et al. (2002) · Nature Medicine · doi:10.1038/nm730 · Cited by 5,025
Complement: a key system for immune surveillance and homeostasis
Ricklin, D., Hajishengallis, G., Yang, K., & Lambris, J. D. (2010) · Nature Immunology · doi:10.1038/ni.1923 · Cited by 3,654 · cited 1×
“cesses and contributes to various immune and inflammatory diseases (2).”
BackgroundSelf-citationWalport, M. J. (2001) · New England Journal of Medicine · doi:10.1056/nejm200104053441406 · Cited by 2,927
Read, S., Malmström, V., & Powrie, F. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.192.2.295 · Cited by 2,205
Wiklund, R. A., & Rosenbaum, S. H. (1997) · New England Journal of Medicine · doi:10.1056/nejm199710163371606 · Cited by 2,149
Pathology and genetics of tumours of the lung , pleura, thymus and heart
Travis, W. D. (2004) · Cited by 1,955
Myeloid-Derived Suppressor Cells: Linking Inflammation and Cancer
Ostrand-Rosenberg, S., & Sinha, P. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0802740 · Cited by 1,736
Role of LAG-3 in Regulatory T Cells
Huang, C.-T., Workman, C. J., Flies, D., Pan, X., Marson, A. L., Zhou, G., Hipkiss, E. L., Ravi, S., Kowalski, J., Levitsky, H. I., et al. (2004) · Immunity · doi:10.1016/j.immuni.2004.08.010 · Cited by 1,325
Rodriguez, P. C., Quiceno, D. G., Zabaleta, J., Ortiz, B., Zea, A. H., Piazuelo, M. B., Delgado, A., Correa, P., Brayer, J., Sotomayor, E. M., et al. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-0465 · Cited by 1,276
Kubota, Y., Kleinman, H. K., Martin, G. R., & Lawley, T. J. (1988) · The Journal of cell biology · doi:10.1083/jcb.107.4.1589 · Cited by 1,209
Methods in molecular medicine.
Craig, R. K. (1987) · BMJ · doi:10.1136/bmj.295.6599.646 · Cited by 1,057
Cross, M. J., & Claesson-Welsh, L. (2001) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(00)01676-x · Cited by 989
Generation of C5a in the absence of C3: a new complement activation pathway
Huber-Lang, M., Sarma, J. V., Zetoune, F. S., Rittirsch, D., Neff, T. A., McGuire, S. R., Lambris, J. D., Warner, R. L., Flierl, M. A., Hoesel, L. M., et al. (2006) · Nature Medicine · doi:10.1038/nm1419 · Cited by 975
Self-citationModulation of the antitumor immune response by complement
Markiewski, M. M., DeAngelis, R. A., Benencia, F., Ricklin-Lichtsteiner, S. K., Koutoulaki, A., Gerard, C., Coukos, G., & Lambris, J. D. (2008) · Nature Immunology · doi:10.1038/ni.1655 · Cited by 778
Self-citationB7-H4 expression identifies a novel suppressive macrophage population in human ovarian carcinoma
Kryczek, I., Zou, L., Rodriguez, P., Zhu, G., Wei, S., Mottram, P., Brumlik, M., Cheng, P., Curiel, T., Myers, L., et al. (2006) · The Journal of Experimental Medicine · doi:10.1084/jem.20050930 · Cited by 748
The role of the anaphylatoxins in health and disease
Klos, A., Tenner, A. J., Johswich, K.-O., Ager, R. R., Reis, E. S., & Köhl, J. (2009) · Molecular Immunology · doi:10.1016/j.molimm.2009.04.027 · Cited by 730 · cited 1×
“riety of biological activities in the immune response (3).”
BackgroundKohler, B. A., Ward, E., McCarthy, B. J., Schymura, M. J., Ries, L. A. G., Eheman, C., Jemal, A., Anderson, R. N., Ajani, U. A., & Edwards, B. K. (2011) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djr077 · Cited by 713
Konishi, J., Yamazaki, K., Azuma, M., Kinoshita, I., Dosaka-Akita, H., & Nishimura, M. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-0428 · Cited by 678
Drusen complement components C3a and C5a promote choroidal neovascularization
Nozaki, M., Raisler, B. J., Sakurai, E., Sarma, J. V., Barnum, S. R., Lambris, J. D., Chen, Y., Zhang, K., Ambati, B. K., Baffi, J. Z., et al. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0408835103 · Cited by 650
Self-citationComplement and coagulation: strangers or partners in crime?
Markiewski, M. M., Nilsson, B., Nilsson Ekdahl, K., Mollnes, T. E., & Lambris, J. D. (2007) · Trends in Immunology · doi:10.1016/j.it.2007.02.006 · Cited by 645
Self-citationImmortalization of human bronchial epithelial cells in the absence of viral oncoproteins
Ramirez, R. D., Sheridan, S., Girard, L., Sato, M., Kim, Y., Pollack, J., Peyton, M., Zou, Y., Kurie, J. M., DiMaio, J. M., et al. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-3703 · Cited by 607
Strainic, M. G., Liu, J., Huang, D., An, F., Lalli, P. N., Muqim, N., Shapiro, V. S., Dubyak, G. R., Heeger, P. S., & Medof, M. E. (2008) · Immunity · doi:10.1016/j.immuni.2008.02.001 · Cited by 580
MEROPS: the peptidase database
Rawlings, N. D., Morton, F. R., Kok, C. Y., Kong, J., & Barrett, A. J. (2007) · Nucleic Acids Research · doi:10.1093/nar/gkm954 · Cited by 520
The parallel lives of angiogenesis and immunosuppression: cancer and other tales
Motz, G. T., & Coukos, G. (2011) · Nature Reviews Immunology · doi:10.1038/nri3064 · Cited by 481
Interaction Between the Coagulation and Complement System
Amara, U., Rittirsch, D., Flierl, M., Bruckner, U., Klos, A., Gebhard, F., Lambris, J. D., & Huber-Lang, M. (2008) · Advances in Experimental Medicine and Biology · doi:10.1007/978-0-387-78952-1_6 · Cited by 471
Self-citationSayan, B. S. (2004) · Cell Death & Differentiation · doi:10.1038/sj.cdd.4401459 · Cited by 388
Brichory, F. M., Misek, D. E., Yim, A.-M., Krause, M. C., Giordano, T. J., Beer, D. G., & Hanash, S. M. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.171320598 · Cited by 353
Pine, S. R., Mechanic, L. E., Enewold, L., Chaturvedi, A. K., Katki, H. A., Zheng, Y.-L., Bowman, E. D., Engels, E. A., Caporaso, N. E., & Harris, C. C. (2011) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djr216 · Cited by 333
Altered Immune Responses in Interleukin 10 Transgenic Mice
Hagenbaugh, A., Sharma, S., Dubinett, S. M., Wei, S. H.-Y., Aranda, R., Cheroutre, H., Fowell, D. J., Binder, S., Tsao, B., Locksley, R. M., et al. (1997) · The Journal of Experimental Medicine · doi:10.1084/jem.185.12.2101 · Cited by 269
Sato, M., Vaughan, M. B., Girard, L., Peyton, M., Lee, W., Shames, D. S., Ramirez, R. D., Sunaga, N., Gazdar, A. F., Shay, J. W., et al. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-2521 · Cited by 263
Cancer and the Complement Cascade
Rutkowski, M. J., Sughrue, M. E., Kane, A. J., Mills, S. A., & Parsa, A. T. (2010) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-10-0225 · Cited by 250
Low-Molecular-Weight Peptidic and Cyclic Antagonists of the Receptor for the Complement Factor C5a
Finch, A. M., Wong, A. K., Paczkowski, N. J., Wadi, S. K., Craik, D. J., Fairlie, D. P., & Taylor, S. M. (1999) · Journal of Medicinal Chemistry · doi:10.1021/jm9806594 · Cited by 246
Complement C3a and C5a Induce Different Signal Transduction Cascades in Endothelial Cells
Schraufstatter, I. U., Trieu, K., Sikora, L., Sriramarao, P., & DiScipio, R. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.169.4.2102 · Cited by 233
Generation of C5a by Phagocytic Cells
Huber-Lang, M., Younkin, E. M., Sarma, J. V., Riedemann, N., McGuire, S. R., Lu, K. T., Kunkel, R., Younger, J. G., Zetoune, F. S., & Ward, P. A. (2002) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)64461-6 · Cited by 212
Complement resistance of tumor cells: basal and induced mechanisms
Jurianz, K., Ziegler, S., Garcia-Schüler, H., Kraus, S., Bohana-Kashtan, O., Fishelson, Z., & Kirschfink, M. (1999) · Molecular Immunology · doi:10.1016/s0161-5890(99)00115-7 · Cited by 199
Mannan-binding lectin activates C3 and the alternative complement pathway without involvement of C2
Selander, B. (2006) · Journal of Clinical Investigation · doi:10.1172/jci25982 · Cited by 183
C5a-Induced Gene Expression in Human Umbilical Vein Endothelial Cells
Albrecht, E. A., Chinnaiyan, A. M., Varambally, S., Kumar-Sinha, C., Barrette, T. R., Sarma, J. V., & Ward, P. A. (2004) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)63173-2 · Cited by 178
Langer, H. F., Chung, K.-J., Orlova, V. V., Choi, E. Y., Kaul, S., Kruhlak, M. J., Alatsatianos, M., DeAngelis, R. A., Roche, P. A., Magotti, P., et al. (2010) · Blood · doi:10.1182/blood-2010-01-261503 · Cited by 176 · cited 1×
“An anti-angiogenic effect of C3 and C5 has been demonstrated in a model of retinopathy of prematurity, where C5a stimulated macrophages toward an angiogenesis-inhibitory phenotype (13).”
BackgroundSelf-citationCTLA‐4: a key regulatory point in the control of autoimmune disease
Scalapino, K. J., & Daikh, D. I. (2008) · Immunological Reviews · doi:10.1111/j.1600-065x.2008.00639.x · Cited by 176
Compstatin: A Complement Inhibitor on its Way to Clinical Application
Ricklin, D., & Lambris, J. D. (2008) · Advances in experimental medicine and biology · doi:10.1007/978-0-387-78952-1_20 · Cited by 162
Self-citationPersistent complement activation on tumor cells in breast cancer.
Niculescu, F. I., Rus, H., Retegan, M., et al. (1992) · PubMed · Cited by 144
Activation of the Lectin Pathway by Natural IgM in a Model of Ischemia/Reperfusion Injury
Zhang, M., Takahashi, K., Alicot, E. M., Vorup‐Jensen, T., Kessler, B. M., Thiel, S., Jensenius, J. C., Ezekowitz, R. A. B., Moore, F. D., & Carroll, M. C. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.177.7.4727 · Cited by 144
Qu, H., Ricklin, D., Bai, H., Chen, H., Reis, E. S., Maciejewski, M., Τζέκου, Α., DeAngelis, R. A., Resuello, R. R. G., Lupu, F., et al. (2012) · Immunobiology · doi:10.1016/j.imbio.2012.06.003 · Cited by 139
Self-citationSerum Interleukin-10 Levels as a Prognostic Factor in Advanced Non-small Cell Lung Cancer Patients
Vita, F. D., Orditura, M., Galizia, G., Romano, C. P., Roscigno, A., Lieto, E., & Catalano, G. (2000) · CHEST Journal · doi:10.1378/chest.117.2.365 · Cited by 135
Ascitic complement system in ovarian cancer
Bjørge, L., Hakulinen, J., Vintermyr, O., Jarva, H., Jensen, T. S., Iversen, O. E., & Meri, S. (2005) · British Journal of Cancer · doi:10.1038/sj.bjc.6602334 · Cited by 133
Expression of Complement Factor H by Lung Cancer Cells
Ajona, D., Castaño, Z., Garayoa, M., Zudaire, E., Pajares, M. J., Martínez, A., Cuttitta, F. F., Montuenga, L. M., & Pío, R. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-2328 · Cited by 132
Self-citationTumor microenvironment is multifaceted
Sautès‐Fridman, C., Cherfils‐Vicini, J., Damotte, D., Fisson, S., Fridman, W. H., Cremer, I., & Dieu‐Nosjean, M. (2011) · Cancer and Metastasis Reviews · doi:10.1007/s10555-011-9279-y · Cited by 118
Serum interleukin-10 levels as a prognostic factor in advanced non-small cell lung cancer patients
Petrovic, M. D., Čekerevac, I., Lazić, Z., & Zdravković, V. (2013) · European Respiratory Journal · doi:10.1183/13993003/erj.42.suppl_57.p2916 · Cited by 112
Ajona, D., Hsu, Y.-F., Corrales, L. P., Montuenga, L. M., & Pı́o, R. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.178.9.5991 · Cited by 107
Self-citationJagels, M. A., Daffern, P. J., & Hugli, T. E. (2000) · Immunopharmacology · doi:10.1016/s0162-3109(99)00178-2 · Cited by 95
Miyata, S., Koshikawa, N., Higashi, S., Miyagi, Y., Nagashima, Y., Yanoma, S., Kato, Y., Yasumitsu, H., & Miyazaki, K. (1999) · The Journal of Biochemistry · doi:10.1093/oxfordjournals.jbchem.a022388 · Cited by 81
Larrea, E., Aldabe, R., Molano, E., Fernández‐Rodríguez, C., Ametzazurra, A., Civeira, M. P., & Prìeto, J. (2005) · Gut · doi:10.1136/gut.2005.070060 · Cited by 81
Regulatory T cells and immune tolerance to tumors
Cao, X. (2009) · Immunologic Research · doi:10.1007/s12026-009-8124-7 · Cited by 79
Efficient osteoclast differentiation requires local complement activation
Tu, Z., Bu, H., Dennis, J. E., & Lin, F. (2010) · Blood · doi:10.1182/blood-2010-01-263590 · Cited by 75
Okrój, M., Hsu, Y.-F., Ajona, D., Pı́o, R., & Blom, A. M. (2007) · Molecular Immunology · doi:10.1016/j.molimm.2007.04.025 · Cited by 75
Self-citationThe plasmin cascade and matrix metalloproteinases in non-small cell lung cancer
Cox, G., Steward, W. P., & O'Byrne, K. J. (1999) · Thorax · doi:10.1136/thx.54.2.169 · Cited by 58
Nguewa, P., Agorreta, J., Blanco, D., Lozano, M. D., Gómez‐Román, J., Sanchez, B. A., Valles, I., Pajares, M. J., Pı́o, R., Rodriguez, M. J., et al. (2008) · BMC Molecular Biology · doi:10.1186/1471-2199-9-103 · Cited by 51
Self-citationHenneke, I., Greschus, S., Savai, R., Korfei, M., Markart, P., Mahavadi, P., SCHERMULY, R. T., Wygrecka, M., Stürzebecher, J., Seeger, W., et al. (2010) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200903-0342oc · Cited by 48
Tumour-associated macrophages in nonsmall cell lung cancer: the role of interleukin-10
Montuenga, L. M., & Pı́o, R. (2007) · European Respiratory Journal · doi:10.1183/09031936.00091707 · Cited by 31
Self-citation
Cited by
Complement System Part II: Role in Immunity
Merle, N. S., Noe, R., Halbwachs-Mecarelli, L., Fremeaux-Bacchi, V., & Roumenina, L. T. (2015) · Frontiers in Immunology · doi:10.3389/fimmu.2015.00257 · Cited by 1,051
Immunosuppressive cells in cancer: mechanisms and potential therapeutic targets
Tie, Y., Tang, F., Wei, Y.-Q., & Wei, X.-W. (2022) · Journal of Hematology & Oncology · doi:10.1186/s13045-022-01282-8 · Cited by 591
Innate Immune Recognition of Cancer
Woo, S.-R., Corrales, L., & Gajewski, T. F. (2015) · Annual Review of Immunology · doi:10.1146/annurev-immunol-032414-112043 · Cited by 571
Self-citationThe role of the complement system in cancer
Afshar-Kharghan, V. (2017) · Journal of Clinical Investigation · doi:10.1172/jci90962 · Cited by 554
Novel mechanisms and functions of complement
Hajishengallis, G., Reis, E. S., Mastellos, D. C., Ricklin, D., & Lambris, J. D. (2017) · Nature Immunology · doi:10.1038/ni.3858 · Cited by 488
Self-citation
Metadata
- Authors
- Corrales, L., Ajona, D., Rafail, S., Lasarte, J. J., Riezu-Boj, J. I., Lambris, J. D., Rouzaut, A., Pajares, M. J., Montuenga, L. M., & Pio, R.
- Venue
- The Journal of Immunology
- Publisher
- Oxford University Press (OUP)
- Published
- 2012-11-01
- Volume
- 189
- Issue
- 9
- Pages
- 4674-4683
- ISSN
- 0022-1767 (ISSN-L)
- 1550-6606
- OpenAlex
- W1900099842
- Cited by
- 281
- References
- 62
- FWCI
- 4.19
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.